|
KR100509388B1
(ko)
|
1996-10-18 |
2005-08-23 |
버텍스 파마슈티칼스 인코포레이티드 |
세린 프로테아제, 특히 간염 ｃ 바이러스 ｎｓ３ 프로테아제의 저해제
|
|
US7491794B2
(en)
*
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
|
US20070237818A1
(en)
*
|
2005-06-02 |
2007-10-11 |
Malcolm Bruce A |
Controlled-release formulation of HCV protease inhibitor and methods using the same
|
|
US20060276404A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Anima Ghosal |
Medicaments and methods combining a HCV protease inhibitor and an AKR competitor
|
|
NZ563365A
(en)
*
|
2005-06-02 |
2011-02-25 |
Schering Corp |
Combination of HCV protease inhibitors with a surfactant
|
|
AU2006252519B2
(en)
|
2005-06-02 |
2012-08-30 |
Merck Sharp & Dohme Corp. |
HCV protease inhibitors in combination with food
|
|
EP1909564A4
(en)
*
|
2005-07-18 |
2010-06-30 |
Novartis Ag |
SMALL ANIMAL MODEL FOR HCV REPLICATION
|
|
MX2008001166A
(es)
|
2005-07-25 |
2008-03-18 |
Intermune Inc |
Nuevos inhibidores macrociclicos de la replicacion del virus de hepatitis c.
|
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
|
AU2006301966A1
(en)
*
|
2005-10-11 |
2007-04-19 |
Array Biopharma, Inc. |
Compounds and methods for inhibiting hepatitis C viral replication
|
|
US7772183B2
(en)
*
|
2005-10-12 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
EP2392589A3
(en)
|
2005-11-11 |
2012-06-20 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
|
JP5260062B2
(ja)
*
|
2006-01-20 |
2013-08-14 |
株式会社カネカ |
β−アミノ−α−ヒドロキシ酸アミド誘導体の製造法
|
|
US7816348B2
(en)
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
EP2007789B1
(en)
|
2006-04-11 |
2015-05-20 |
Novartis AG |
Spirocyclic HCV/HIV inhibitors and their uses
|
|
WO2007120595A2
(en)
*
|
2006-04-11 |
2007-10-25 |
Novartis Ag |
Amines for the treatment of hcv
|
|
CA2651762A1
(en)
|
2006-05-23 |
2007-11-29 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
|
WO2007138928A1
(ja)
*
|
2006-05-26 |
2007-12-06 |
Kaneka Corporation |
光学活性３－アミノ－２－ヒドロキシプロピオン酸シクロプロピルアミド誘導体およびその塩の製造方法
|
|
US9526769B2
(en)
*
|
2006-06-06 |
2016-12-27 |
Enanta Pharmaceuticals, Inc. |
Macrocylic oximyl hepatitis C protease inhibitors
|
|
PE20080992A1
(es)
*
|
2006-06-26 |
2008-08-06 |
Enanta Pharm Inc |
Quinoxalinil macrociclicos inhibidores de serina proteasa del virus de la hepatitis c
|
|
DE102006059317A1
(de)
|
2006-07-04 |
2008-01-10 |
Evonik Degussa Gmbh |
Verfahren zur Herstellung von β-Amino-α-hydroxy-carbonsäureamiden
|
|
KR20090024834A
(ko)
*
|
2006-07-05 |
2009-03-09 |
인터뮨, 인크. |
Ｃ형 간염 바이러스 복제의 신규 억제제
|
|
US7662779B2
(en)
*
|
2006-08-11 |
2010-02-16 |
Enanta Pharmaceuticals, Inc. |
Triazolyl macrocyclic hepatitis C serine protease inhibitors
|
|
JP2010500978A
(ja)
|
2006-08-17 |
2010-01-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ウイルスポリメラーゼインヒビター
|
|
WO2008027397A2
(en)
*
|
2006-08-28 |
2008-03-06 |
Vertex Pharmaceuticals Incorporated |
Method for identifying protease inhibitors
|
|
US20100216161A1
(en)
|
2009-02-26 |
2010-08-26 |
Vertex Pharmaceuticals Incorporated |
Method for identifying protease inhibitors
|
|
DE102006042147A1
(de)
*
|
2006-09-06 |
2008-03-27 |
Dynamit Nobel Gmbh Explosivstoff- Und Systemtechnik |
Hydrochloride von 3-Amino-2-hydroxycarbonsäureamiden
|
|
US8003604B2
(en)
*
|
2006-11-16 |
2011-08-23 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CA2673111A1
(en)
|
2006-12-07 |
2008-06-19 |
Schering Corporation |
Ph sensitive matrix formulation
|
|
AU2008214217B2
(en)
|
2007-02-09 |
2011-10-13 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
|
EP2160392A2
(en)
*
|
2007-05-03 |
2010-03-10 |
Intermune, Inc. |
Novel macrocyclic inhibitors of hepatitis c virus replication
|
|
WO2008141227A1
(en)
*
|
2007-05-10 |
2008-11-20 |
Intermune, Inc. |
Novel peptide inhibitors of hepatitis c virus replication
|
|
US20090005387A1
(en)
*
|
2007-06-26 |
2009-01-01 |
Deqiang Niu |
Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors
|
|
CA2693997C
(en)
|
2007-08-03 |
2013-01-15 |
Pierre L. Beaulieu |
Viral polymerase inhibitors
|
|
AR068756A1
(es)
*
|
2007-10-10 |
2009-12-02 |
Novartis Ag |
Compuestos peptidicos, formulacion farmaceutica y sus usos como moduladores del virus de la hepatitis c
|
|
US8419332B2
(en)
*
|
2007-10-19 |
2013-04-16 |
Atlas Bolt & Screw Company Llc |
Non-dimpling fastener
|
|
US8268777B2
(en)
*
|
2007-12-05 |
2012-09-18 |
Enanta Pharmaceuticals, Inc. |
Oximyl macrocyclic derivatives
|
|
CN101903351B
(zh)
|
2007-12-19 |
2014-09-10 |
贝林格尔.英格海姆国际有限公司 |
病毒聚合酶抑制剂
|
|
JP2011051896A
(ja)
*
|
2007-12-21 |
2011-03-17 |
Kaneka Corp |
Ｎ−シクロプロピル−３−アミノ−２−ヒドロキシヘキサン酸アミド塩酸塩の製造方法
|
|
EA201071034A1
(ru)
|
2008-04-15 |
2011-06-30 |
Интермьюн, Инк. |
Новые макроциклические ингибиторы репликаций вируса гепатита с
|
|
US20090285773A1
(en)
*
|
2008-05-15 |
2009-11-19 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
CN101580535B
(zh)
*
|
2008-05-16 |
2012-10-03 |
太景生物科技股份有限公司 |
丙型肝炎病毒蛋白酶抑制剂
|
|
WO2009148923A1
(en)
*
|
2008-05-29 |
2009-12-10 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
|
UY32099A
(es)
|
2008-09-11 |
2010-04-30 |
Enanta Pharm Inc |
Inhibidores macrocíclicos de serina proteasas de hepatitis c
|
|
US20100272674A1
(en)
*
|
2008-12-04 |
2010-10-28 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
JP2012514605A
(ja)
|
2009-01-07 |
2012-06-28 |
サイネクシス，インコーポレーテッド |
Ｈｃｖおよびｈｉｖ感染の治療への使用におけるシクロスポリン誘導体
|
|
AR075584A1
(es)
|
2009-02-27 |
2011-04-20 |
Intermune Inc |
COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
|
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
|
JP2012528195A
(ja)
|
2009-05-29 |
2012-11-12 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Ｃ型肝炎などの疾患を処置するための３つの結合アリール部分で構成された抗菌性化合物
|
|
US8232246B2
(en)
*
|
2009-06-30 |
2012-07-31 |
Abbott Laboratories |
Anti-viral compounds
|
|
HUE030402T2
(en)
*
|
2009-09-15 |
2017-05-29 |
Taigen Biotechnology Co Ltd |
HCV protease inhibitors
|
|
EP2503881B1
(en)
|
2009-11-25 |
2015-05-13 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
|
AU2010341537A1
(en)
|
2009-12-22 |
2012-08-09 |
Merck Sharp & Dohme Corp. |
Fused Tricyclic Compounds and methods of use thereof for the treatment of viral diseases
|
|
US20110178107A1
(en)
*
|
2010-01-20 |
2011-07-21 |
Taigen Biotechnology Co., Ltd. |
Hcv protease inhibitors
|
|
US8686145B2
(en)
*
|
2010-02-25 |
2014-04-01 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patientenzorg C/O Technology Transfer Officer VU & Vumc |
Process for the preparation of α-acyloxy β-formamido amides
|
|
EP2545060B1
(en)
|
2010-03-09 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
|
|
AU2011286276A1
(en)
|
2010-07-26 |
2013-01-24 |
Merck Sharp & Dohme Corp. |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
|
JP2013540122A
(ja)
|
2010-09-29 |
2013-10-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
|
|
CA2822556A1
(en)
|
2010-12-30 |
2012-07-05 |
Enanta Pharmaceuticals, Inc |
Macrocyclic hepatitis c serine protease inhibitors
|
|
EA201390988A1
(ru)
|
2010-12-30 |
2014-04-30 |
Энанта Фармасьютикалз, Инк. |
Фенантридиновые макроциклические ингибиторы сериновой протеазы вируса гепатита c
|
|
BR112013026345A2
(pt)
|
2011-04-13 |
2019-04-24 |
Merck Sharp & Dohe Corp. |
composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
|
|
EP2697242B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
|
WO2013033901A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2013033899A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
|
|
WO2013033900A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
|
|
EP2755981A4
(en)
|
2011-09-14 |
2015-03-25 |
Merck Sharp & Dohme |
SILICULAR HETEROCYCLIC DERIVATIVES AND METHOD FOR THEIR USE FOR THE TREATMENT OF VIRUS DISEASES
|
|
AR091192A1
(es)
|
2012-05-30 |
2015-01-21 |
Chemo Iberica Sa |
Procedimiento multicomponente para la preparacion de compuestos biciclicos
|
|
CN104812733A
(zh)
|
2012-06-13 |
2015-07-29 |
詹森药业有限公司 |
一种用于制备3-氨基-n-环丙基-2-羟基-己酰胺的方法
|
|
CN102875649B
(zh)
*
|
2012-09-26 |
2014-04-16 |
深圳翰宇药业股份有限公司 |
一种制备特拉匹韦及其中间体的方法及所述中间体
|
|
CN102875648B
(zh)
*
|
2012-09-26 |
2014-02-19 |
深圳翰宇药业股份有限公司 |
一种制备特拉匹韦的方法
|
|
EP3063140A4
(en)
|
2013-10-30 |
2017-11-08 |
Merck Sharp & Dohme Corp. |
Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
|
|
CN104610272B
(zh)
*
|
2013-11-05 |
2017-03-29 |
上海唐润医药科技有限公司 |
环状黄酮或异黄酮类化合物及其用途
|
|
WO2015103490A1
(en)
|
2014-01-03 |
2015-07-09 |
Abbvie, Inc. |
Solid antiviral dosage forms
|
|
JP2018131439A
(ja)
*
|
2017-02-14 |
2018-08-23 |
アッヴィ・インコーポレイテッド |
Ｈｃｖを処置する方法
|
|
US11124497B1
(en)
|
2020-04-17 |
2021-09-21 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
US11174231B1
(en)
|
2020-06-09 |
2021-11-16 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
JP2023533016A
(ja)
|
2020-07-11 |
2023-08-01 |
ファイザー・インク |
抗ウイルス性ヘテロアリールケトン誘導体
|
|
US11351149B2
(en)
|
2020-09-03 |
2022-06-07 |
Pfizer Inc. |
Nitrile-containing antiviral compounds
|